Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT03553251
Eligibility Criteria:
Inclusion Criteria:
* Children under 16 years of age coming for a consultation for a beta-lactam oral reintroduction test.
Exclusion Criteria:
* Refusal of the legal representatives of the subject for their child to participate in the study,
* If his age permits, refusal of the subject to participate in the study,
* Subject aged over 16,
* Pregnancy,
* Absence of affiliation of the subject to a social security scheme,
* Skin tests with incriminated beta-lactam already made before the consultation,
* Existence of contraindications to the realization of oral reintroduction drug test with the suspected antibiotic,
* Existence of criteria in the initial reaction suggestive of a non-low risk of IgE-mediated or delayed hypersensitivity to the incriminated beta-lactam, Taking antihistamine, corticosteroids or beta-blockers within 5 days prior to the oral reintroduction drug test,
* Travel abroad of the child scheduled within 7 days of the oral reintroduction drug test.
Healthy Volunteers:
True
Sex:
ALL
Maximum Age:
16 Years
Study:
NCT03553251
Study Brief:
Protocol Section:
NCT03553251